Ivan Fedyunin

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.

Part of Bioprocess Holding, Pharmapark LLC is a privately-owned Russian biopharmaceutical company that specializes in the development, manufacture, and commercialization of biosimilar products. The company is based in Moscow, Russian Federation. The company has a successful track record of performing complete biotechnological drug development through commercial production and has marketed five biosimilar products. Pharmapark also has an in-house pipeline of novel formulations and biosimilars focused on value-adding treatments.

Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation.

BrainQ Technologies Ltd. develops a detection and non-invasive treatment technology to help patients with paralysis move their limbs. The company was founded by Segal Yaron, Drechsler Yotam, and Shohami Emerita Esther on August 14, 2011 and is headquartered in Jerusalem, Israel.